Comparative-Effectiveness

How Does Crossover Affect Overall Survival Analysis In Randomized Controlled Trials

Videos Promote Ethical Comparative-Effectiveness Research

AMCP’s Pre-Conference Comparative Effectiveness Research Certificate Program

The Politics Of Pharma Pricing: Are We Asking The Right Questions?

Are U.S. Cancer Patients Receiving Better Care Than Europeans?

Does PCORI Have The Capacity To Promote Significant Change?

Symposium On Innovation & Cost-Effectiveness Analysis

EBM – Time To Refresh And Redefine?

Will CER Really Deliver Better Patient Outcomes?

Barriers And Opportunities Of Big Data

CER – What Happens When The Patient Is Not Your “Average” Patient?

How Can We Use RCT Data To Assess Heterogeneity Of Treatment Effecs? Let Me Count The Ways

Scenario-Building Methods And US Scenarios

PCORnet – Enabling Comparative Effectiveness Research In The US

What Can Winnie The Pooh Teach Us About Pharmaceutical Reimbursement?

Evidence Based Medicine: A Movement In Crisis?

Is U.S. Medicare Program’s Use Of CER Consistent With The ACA’s Restrictions?

A Discussion Of Approaches To Knowledge Synthesis

Is Patient-Centricity A Farce?

How Will PCORI’s National Database Revolutionize Research?

Is Medicare Setting Trends With Heterogeneity?

Is Heterogeneity The Key To Fairness Among Health Plans?

Heterogeneity – The Good, The Bad, And The Different

Congratulations To These New GNS Healthcare Scientific Advisory Board Members!

What Does The CTAF Have To Say About New Hepatitis C Treatments

What Does PCORI’s Executive Director Have To Say About NPC’s Survey Results?

PCORI Puts Up $90M For Large Pragmatic Study Proposals

Do Stakeholders Find CER Important Or Relevant?

PCORnet Is In The Spotlight! Are You Following?

National Pharmaceutical Council Survey Declares PCORI A Leader

Categories

Stay Connected